Cargando…
Osteoprotegerin in breast cancer: beyond bone remodeling
Osteoprotegerin (OPG) is a secreted protein and member of the Tumor Necrosis Factor (TNF) Receptor superfamily. OPG has been well characterized as a regulator of bone metabolism which acts by blocking osteoclast maturation and preventing bone breakdown. Given this role, early studies on OPG in breas...
Autores principales: | Weichhaus, Michael, Chung, Stephanie Tsang Mui, Connelly, Linda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460694/ https://www.ncbi.nlm.nih.gov/pubmed/26054853 http://dx.doi.org/10.1186/s12943-015-0390-5 |
Ejemplares similares
-
Osteoprotegerin expression in triple-negative breast cancer cells promotes metastasis
por: Weichhaus, Michael, et al.
Publicado: (2014) -
Osteoprotegerin mediates tumor-promoting effects of Interleukin-1beta in breast cancer cells
por: Chung, Stephanie Tsang Mui, et al.
Publicado: (2017) -
Osteoprotegerin: Relationship to Breast Cancer Risk and Prognosis
por: Geerts, Dirk, et al.
Publicado: (2020) -
The roles of osteoprotegerin in cancer, far beyond a bone player
por: Wang, Yufei, et al.
Publicado: (2022) -
Role of RANKL–RANK/osteoprotegerin molecular complex in bone remodeling and its immunopathologic implications
por: Kohli, Sarvraj Singh, et al.
Publicado: (2011)